We read with interest the paper by Li et al.entitled“Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in stage...We read with interest the paper by Li et al.entitled“Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma:a randomized comparative study”(1).展开更多
Liver cancer is the fourth leading cause of cancer-related death worldwide.Hepatocellular carcinoma(HCC),the most prevalent cause of primary liver cancer,is observed highest in the Far East,South-Eastern Asia and East...Liver cancer is the fourth leading cause of cancer-related death worldwide.Hepatocellular carcinoma(HCC),the most prevalent cause of primary liver cancer,is observed highest in the Far East,South-Eastern Asia and East Africa(1).In most endemic regions this is secondary to the prevalence of specific risk factors including chronic hepatitis B virus(HBV)infection,hepatitis C virus(HCV)infection and aflatoxin-exposure(1,2).The development of HBV vaccination and programmes to reduce HBV transmission has reduced the risk of HCC in high-risk Asian countries(1).Global incidence of HCC however continues to rise and major contributory factors to this are alcohol misuse and the obesity epidemic,resulting in non-alcoholic fatty liver disease,in Western nations(1,2).展开更多
文摘We read with interest the paper by Li et al.entitled“Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma:a randomized comparative study”(1).
文摘Liver cancer is the fourth leading cause of cancer-related death worldwide.Hepatocellular carcinoma(HCC),the most prevalent cause of primary liver cancer,is observed highest in the Far East,South-Eastern Asia and East Africa(1).In most endemic regions this is secondary to the prevalence of specific risk factors including chronic hepatitis B virus(HBV)infection,hepatitis C virus(HCV)infection and aflatoxin-exposure(1,2).The development of HBV vaccination and programmes to reduce HBV transmission has reduced the risk of HCC in high-risk Asian countries(1).Global incidence of HCC however continues to rise and major contributory factors to this are alcohol misuse and the obesity epidemic,resulting in non-alcoholic fatty liver disease,in Western nations(1,2).
